Volume | 95,316 |
|
|||||
News | - | ||||||
Day High | 0.70 | Low High |
|||||
Day Low | 0.661278 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Biomerica Inc | BMRA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.6754 | 0.661278 | 0.70 | 0.665226 | 0.67535 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
416 | 95,316 | US$ 0.6853924 | US$ 65,329 | - | 0.66 - 2.13 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:50:52 | formt | 710 | US$ 0.69 | USD |
Biomerica Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
11.27M | 16.82M | - | 5.34M | -7.14M | -0.42 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Biomerica News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BMRA Price Data
Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.75 | 0.80 | 0.66 | 0.7102943 | 183,031 | -0.06 | -8.00% |
1 Month | 0.8851 | 0.91 | 0.66 | 0.7610536 | 101,225 | -0.1951 | -22.04% |
3 Months | 0.9155 | 1.35 | 0.66 | 0.9024846 | 71,417 | -0.2255 | -24.63% |
6 Months | 0.99 | 2.13 | 0.66 | 1.55 | 644,720 | -0.30 | -30.30% |
1 Year | 1.27 | 2.13 | 0.66 | 1.54 | 395,407 | -0.58 | -45.67% |
3 Years | 4.48 | 7.38 | 0.66 | 4.02 | 389,622 | -3.79 | -84.60% |
5 Years | 2.47 | 23.39 | 0.66 | 5.94 | 402,721 | -1.78 | -72.06% |
Biomerica Description
Biomerica Inc is engaged in the development, manufacturing, and marketing medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. Majority of the company's revenue is earned from the Europe market. |